Dr. Reddy’s Secures Exclusive Rights to Commercialize HLX15 in U.S. & Europe EP News Bureau Feb 6, 2025 HLX15 is a recombinant anti-CD38 fully human monoclonal antibody injection, with intravenous as well as subcutaneous formulations
Dr Reddy’s launches generic opioid antagonist injection in US Press Trust of India Mar 20, 2020 The product is a generic version of ADAPT Pharma Operations's Narcan injection
Warning letter woes: Dr Reddy’s expects FDA inspection of AP plant by year-end Press Trust of India Aug 1, 2019 The company's API plant at Miryalaguda was given an Establishment Inspection Report (EIR) in 2017 resolving the earlier warning…
